Valsartan And Hydrochlorothiazide Tablet
Product Images NDC 50090-6210

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-6210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906210)

Packaging label for Valsartan and Hydrochlorothiazide tablets, showing strength of 160 mg/25 mg. The label indicates oral tablet form, packaging of 90 tablets, and instructions to store at 68 to 77 degrees Fahrenheit and protect from moisture. The labeler is A-S Medication Solutions, Libertyville, IL, with product NDC 50090-6210.*

FDA Label Image

Figure-1 (Valsartan Hctz Figure 1)

A line graph showing the percentage of patients with systolic blood pressure (SBP) below 140 mmHg plotted against baseline SBP values ranging from 140 to 180 mmHg. It compares four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, with each group represented by distinct symbols and lines.*

FDA Label Image

Figure-2 (Valsartan Hctz Figure 2)

A line graph showing the percentage of patients with diastolic blood pressure (DBP) less than 90 mmHg plotted against baseline DBP values (90 to 110 mmHg). Four treatment groups are compared: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, each represented by distinct symbols and lines that decline as baseline DBP increases.*

FDA Label Image

Figure-3 (Valsartan Hctz Figure 3)

A line graph showing the percentage of patients achieving systolic blood pressure (SBP) <130 mmHg based on baseline SBP (mmHg). It compares four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo, with Valsartan HCT showing the highest percentage response across baseline SBP values.*

FDA Label Image

Figure-4 (Valsartan Hctz Figure 4)

A line chart illustrating the percentage of diastolic blood pressure (DBP) readings below 80 mmHg plotted against baseline DBP values from 90 to 110 mmHg. The chart compares four groups: Valsartan HCT 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, each represented by different symbols in the legend. The y-axis shows the percentage, while the x-axis shows baseline DBP in mmHg.*

FDA Label Image

Hctz-stru (Valsartan Hctz Hydrochlorothiazide)

Chemical structure of valsartan and hydrochlorothiazide showing the molecular arrangement of atoms including sulfonamide, chlorine, nitrogen, and oxygen groups in a bicyclic aromatic system.*

FDA Label Image

Valsartan-str (Valsartan Hctz Valsartan)

Chemical structure of valsartan showing its molecular configuration including benzene rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.